We use science to save lives, and so can you. We are currently recruiting for a Head of Legal Operations to assist the General Counsel on all UK legal operational and compliance matters. Your responsibilities in this role would be: UK Site Legal Operational matters • Advise on operational legal matters arising across the UK site, including issues relating to suppliers, facilities and UK site services • Support the Contracts teams with the drafting and amending of contracts/ t’s & c’s, work orders, etc relating to supplier’s, facilities and UK Site services • Support the Contracts team, advising on general English law queries • Support the Contracts Group with the creation and maintenance of template legal contracts Legal Compliance • Proactively work with the UK Site Head and UK Site leadership team to ensure that the Company conducts business in compliance with all applicable laws and regulations, OXB Polices and SOP’s • Proactively assess risk in the UK Site and work with relevant departments to ensure robust policies/ SOP’s are in place to reduce and mitigate such risk • Analyse existing processes for legal and compliance matter management, and work with departments to develop process improvements and other efficiencies • Work with the Head of France to develop and monitor core global legal SOP’s/ Policies, including, Data Protection, Anti- bribery, confidentiality, etc • Work with the Deputy GC to the coordinate global and site-specific training opportunities on particular policies. • Participate in risk management meetings Litigation • Advise on supplier litigation • Advise on client litigation Data protection • Participate in the Data Protection Group • Keep abreast of GDPR regulatory/ reporting requirements • Assist with data protection issues arising through UK site operations • Assist with document retention policy roll out • Assist with Data Protection policy management and updates Litigation • Liaise with outside counsel on litigation matters • Assist with management of contentious matters ESG • Keep abreast of ESG best practice and regulatory/ reporting requirements • Work with the UK Site Head and other key business stakeholders to help drive a sustainable culture throughout the business focusing on the Group’s ESG strategy and recommend ESG best practice in line with regulatory and reporting guidelines Crisis management Primary point of contact for legal operational advice on UK Site Crisis Management issues Budget Assist with the Legal Department’s budget and forecasting processes and monitor the budget to control costs We are looking for: Minimum Entry Level of Education Required for the Role • Solicitor with current practising certificate • (LLB) Hons Functional Knowledge Required in the Role • Good understanding of general commercial law • Good understanding of supplier contracts and operational legal issues Innovation and Problem Solving • Ability to review and provide advice on various legal and commercial matters Team working and Leadership • Ability to work both independently and as part of a larger cross-departmental team to solve complex/ sensitive legal issues. Communication and Influencing Skills • Good communicator and confidence to deliver legal advice to Senior Leaders in the business Other Required Personal Attributes • Confidence; ability to work under pressure; ability to work on multiple issues at the same time; ability to instruct and liaise with outside counsel About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. What’s in it for you: • Highly competitive total reward packages • Wellbeing programmes • Development opportunities • Welcoming, friendly, supportive colleagues • A diverse and inclusive working environment • Our values are: Responsible, Responsive, Resilient, Respect • State of the art laboratory and manufacturing facilities We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you. Collaborate. Contribute. Change lives Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.